Sanggenon C is primarily studied for its significant biological activities, particularly in the field of pharmacology. It exhibits strong anti-inflammatory effects by inhibiting key signaling pathways such as NF-κB and MAPK, making it a potential candidate for treating inflammatory diseases. Research also shows that Sanggenon C has neuroprotective properties, which could be beneficial in managing neurodegenerative conditions like Alzheimer’s disease due to its ability to reduce oxidative stress and prevent neuronal cell damage. It demonstrates potent antioxidant activity, helping to neutralize free radicals and reduce cellular damage. This property is useful in anti-aging formulations and in protecting against chronic diseases linked to oxidative stress. Additionally, Sanggenon C has been investigated for its anticancer potential, where it induces apoptosis and suppresses proliferation in various cancer cell lines, including those of the liver, breast, and lung. Due to its ability to modulate metabolic enzymes and improve insulin sensitivity, it is also explored for use in managing metabolic disorders such as diabetes. Overall, Sanggenon C holds promise as a multi-target therapeutic agent in natural product-based drug development.